NRXP

NRx Pharmaceuticals, Inc. (NRXP) is a clinical-stage biopharmaceutical company headquartered in Wilmington, Delaware, dedicated to developing pioneering therapies for severe central nervous system disorders and respiratory diseases. The company is committed to addressing unmet medical needs through its proprietary technologies and innovative research, resulting in a promising pipeline that targets critical health challenges. As NRX advances its drug candidates through rigorous clinical trials, it aims to significantly impact patient care and transform treatment paradigms in its respective therapeutic areas.